Question: how long has xtandi been on the market?
Answer: "XTANDI has been established as a standard of care for men with castration-resistant prostate cancer and has been prescribed to more than 420,000 patients worldwide since it was first approved in 2012," said Andrew Krivoshik, M.D., Ph. D., Senior Vice President and Oncology Therapeutic Area Head at Astellas.